Resource Logo
BETA

HIV/AIDS and Diabetes: Minimizing Risk, Optimizing Care




 

Recent literature about diabetes and disorders of glucose metabolism in people with HIV/AIDS contains conflicting messages. Some studies indicate an increased risk of diabetes mellitus (generally referred to simply as “diabetes”) in people taking HAART, specifically protease inhibitors (PIs). Other studies indicate that nucleoside reverse transcriptase inhibitors (NRTIs) are the culprit.

Read more...



 


Copyright © 2009 -BETA, Publisher. All rights reserved to the San Francisco AIDS Foundation. Reproduced by permission. Reproduction of this article (other than one copy for personal reference) must be cleared through BETA: PO Box 426182, San Francisco, CA 94142-6182. Tel: 415 487 8060 Fax: 415 487 8069 San Francisco AIDS Foundation, Mail SFAF..

Information in this article was accurate in March 10, 2009. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.